Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC278 rollover access study in HIV-1 infected adults previously treated with TMC278
NL-OMON36498Phase 3Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rilpivirine in Human immunodeficiency virus infection type 1, sponsored by Janssen Pharmaceutical. Started Sep 2011; status: active, not recruiting.
02
Drugs
rilpivirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON36498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36498.